Neuromon is a small company erected in 2005 that aims to improve technology for hemodynamic monitoring of the brain. The primary goal of Neuromon is to make new technology available for the intensive care monitoring of severely ill neurological patients. It is expected that this new technology will improve the standards of neurovascular monitoring and thereby allow doctors to achieve a better outcome in individual patients. Neuromon is licensed for the application of PaR-technology. Neuromon recently introduced major improvements in TCD-parameterization.